Inhibitor Therapeutics (INTI) Return on Equity [ROE] (2014 - 2025)
Inhibitor Therapeutics (INTI) recorded Return on Equity [ROE] of -952.30% in FY2025, down 860.43 percentage points from -91.87% in FY2024.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Return on Equity [ROE] (2014 - 2025) Analysis & Trends
Starting with FY2015, Inhibitor Therapeutics' Return on Equity [ROE] history includes 8 years.
- Annual Return on Equity [ROE] has declined for three straight years, with a three-year change of -1470.16 percentage points (FY2022 to FY2025).
- The FY2025 figure is the lowest annual Return on Equity [ROE] since FY2018.
- Per Business Quant data, INTI's Return on Equity [ROE] was -91.87% in FY2024 (-47.31 pp), -44.57% in FY2023 (-562.43 pp) and 517.86% in FY2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Inhibitor Therapeutics | 17.38 Mn | 17.38 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -953.10% |
| Jun 30, 2025 | -333.26% |
| Mar 31, 2025 | -197.01% |
| Dec 31, 2024 | -123.86% |
| Sep 30, 2024 | -81.77% |
| Jun 30, 2024 | -68.79% |
| Mar 31, 2024 | -63.92% |
| Dec 31, 2023 | -51.57% |
| Sep 30, 2023 | -33.70% |
| Jun 30, 2023 | -22.85% |
| Mar 31, 2023 | -13.98% |
| Dec 31, 2022 | -31.89% |
| Dec 31, 2017 | -836.93% |
| Sep 30, 2017 | -502.23% |
| Jun 30, 2017 | -391.62% |
| Mar 31, 2017 | -183.67% |
| Dec 31, 2016 | -134.74% |
| Sep 30, 2016 | -137.62% |
| Jun 30, 2016 | -239.52% |
| Mar 31, 2016 | -8,343.55% |
API Access
Inhibitor Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();